Digital health companies (DHCs) and their solutions continue to grow at a rapid pace. This is in part being fueled by the record funding for DHCs, with over $29 billion for US-based companies in 2021 alone. As a result, patients are inundated with solutions from every direction – from employers, health plans, and directly through consumer-oriented apps and wearables. Physicians are also getting into the mix by directly prescribing digital therapeutics. On the surface, the blossoming of the
Read More
Biofourmis Secures $300M to Expand Virtual Care Offerings
What You Should Know: - Biofourmis, a global leader in virtual care and digital medicine raises $300 million in Series D investment led by leading global growth equity firm General Atlantic. CVS Health and existing investors also participated in the round, - Biofourmis also announced that former Medtronic CEO and Chairperson at Intel, Dr. Omar Ishrak, will join the company’s Board of Directors as Chairman. Transforming Patient Health Through Personalized, Predictive Care Founded in
Read More
physIQ, CellCarta Collaborate on Study to Revolutionize Vaccine
What You Should Know: - Today, digital medicine leader physIQ and CellCarta, a global leader in precision medicine services announced they are collaborating on a groundbreaking study that could revolutionize vaccine development. - The strategic collaboration advances the detailed study of early, individualized human responses to vaccinations as pharma companies race to deliver safe, effective vaccines sooner. physIQ, a pioneer in digital medicine, and CellCarta, a global leader in
Read More
AppliedVR Lands $29M for VR Platform to Treat Chronic Pain
What You Should Know: - AppliedVR, a Los Angeles, CA-based company advancing the next generation of digital medicine, today announced $29 million in Series A funding, bringing its total funds raised to date to $35 million. The round, which includes key investors F-Prime Capital, JAZZ Venture Partners, Sway Ventures, GSR Ventures, Magnetic Ventures and Cedars-Sinai, will fuel the company’s growth as it pursues full FDA approval over the next year. - Founded in 2015, AppliedVR provides
Read More
Executive Hires: Walgreens Appoints New CEO, Cityblock Health, Innovaccer, Others
Walgreens appoints Rosalind (Roz) Brewer as the company’s Chief Executive Officer, effective on March 15, 2021. Brewer will also join the WBA Board of Directors upon assuming the role. She succeeds Stefano Pessina who, as previously announced, will transition to the role of Executive Chairman of the Board of WBA. Brewer, 58, will become the first Black woman to lead a Fortune 500 company. Former Livongo President, Jennifer Schneider, has joined Cityblock Health’s Board of
Read More
Nuance Launches AI-Powered Patient Engagement Virtual Assistant Platform
What You Should Know: - Nuance Communications, Inc. launched an AI-powered
patient engagement virtual assistant platform to transform omnichannel digital
experiences for patients. - Healthcare provider organizations can now deploy
a single, common cloud-based platform to support their entire patient journey
across engagement channels using Nuance's market-leading Intelligent Engagement
AI technology - The launch comes as patients increasingly expect the
same level of engaging
Read More
FDA Grants AppliedVR Breakthrough Designation for Virtual Reality Chronic Pain Treatment
What You Should Know: - FDA awards AppliedVR Breakthrough Device designation for
treating treatment-resistant fibromyalgia and chronic intractable lower back
pain - AppliedVR’s EaseVRx program helps patients learn self-management skills grounded in evidence-based cognitive-behavioral therapy (CBT) principles and other behavioral methods. AppliedVR,
a pioneer advancing the next generation of digital medicine, today announced
its EaseVRx product received Breakthrough Device designation
Read More
NIH Taps PhysIQ to Develop AI-Based COVID-19 Digital Biomarker
What You Should Know: - physIQ has been selected by the National Institute of Health (NIH) to develop an innovative AI-based COVID-19 digital biomarker solution to address the COVID-19 pandemic. - Early detection of COVID-19 decompensation in patients
is complicated by infrequent and non-specific clinical data. The first-in-kind
tool will collect and analyzes continuous physiologic data could provide early
clinical indicators of COVID-19 decompensation. The National Cancer
Institute
Read More
Biofourmis Lands $100M to Expand AI-Powered Digital Therapeutics Platform
What You Should Know: - Boston-based digital therapeutics leader Biofourmis
just closed a $100 million Series C funding round led by SoftBank,
bringing its total funding to $145M. - Biofourmis will be using the funding to develop, validate and commercialize several released and unreleased digital therapeutics solutions across cardiology, oncology, respiratory, and pain, with a focus on the United States and key Asian markets, including Asia Pacific, China, and
Read More
Noteworth Lands $5M to Expand All-in-One Care Delivery Platform
What You Should Know: - Noteworth, a first-of-its-kind Digital Healthcare
platform for modernizing Digital Medicine delivery operations, secured a $5
million oversubscribed seed funding round led by Laconia Capital Group - With this investment, the company will continue to
build upon the delivery of Noteworth’s first-of-its-kind Digital Healthcare
platform. Noteworth,
a Hoboken, NJ-based all-in-one-care delivery platform for modernizing digital medicine
delivery
Read More
